Brodalumab Subcutaneous and Xpect-AT
Determining the interaction of Brodalumab Subcutaneous and Xpect-AT and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brodalumab
Brand name: Siliq
Synonyms: Brodalumab
Generic Name: carbetapentane / guaifenesin
Brand name: Allfen C, Allfen CX, Xpect-AT, BetaVent, Oratuss, Pulmari-GP, Certuss, Dynex VR, Carba-XP, AMBI 1000/5, Duratuss CS, Respi-Tann G, Allres-G, Tusso-ZR, Tusso-ZMR, exall, Expectuss
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brodalumab Subcutaneous-Xpect-PE
- Brodalumab Subcutaneous-Xpovio
- Brodalumab Subcutaneous-Xpovio (100 MG Once Weekly)
- Brodalumab Subcutaneous-Xpovio (60 MG Once Weekly)
- Brodalumab Subcutaneous-Xpovio (80 MG Once Weekly)
- Brodalumab Subcutaneous-Xpovio (80 MG Twice Weekly)
- Xpect-AT-Brodspec
- Xpect-AT-Brom Mal Phenyl HCl Dex HBr
- Xpect-AT-Bromaline
- Xpect-AT-Bromaline DM
- Xpect-AT-Bromatan Plus
- Xpect-AT-Bromatan-DM